Recent progress in the use of glycine transporter-1 inhibitors for the treatment of central and peripheral nervous system diseases
A Slassi, I Egle - Expert Opinion on Therapeutic Patents, 2004 - Taylor & Francis
The recent discovery of glycine transporters in both the CNS and the periphery suggests that
the glycine transporter may play a critical role in NMDA receptor function by modulating …
the glycine transporter may play a critical role in NMDA receptor function by modulating …
Glycine transporter 1 inhibitors and modulation of NMDA receptor-mediated excitatory neurotransmission
C Sur, GG Kinney - Current drug targets, 2007 - ingentaconnect.com
In the central nervous system, glutamate is essential for a proper synaptic communication in
neuronal networks supporting critical behavioral activities such as learning and memory …
neuronal networks supporting critical behavioral activities such as learning and memory …
Glycine transport inhibitors as potential antipsychotic drugs
KR Aubrey, RJ Vandenberg - Expert Opinion on Therapeutic …, 2001 - Taylor & Francis
Current antipsychotic drugs are only partially effective in treating schizophrenia and there is
a clear need to develop better therapies. An alternative approach to develop new …
a clear need to develop better therapies. An alternative approach to develop new …
Glycine transporter inhibitors as therapeutic agents for schizophrenia
K Hashimoto - Recent Patents on CNS Drug Discovery …, 2006 - ingentaconnect.com
Multiple lines of evidence suggest that a dysfunction in the glutamatergic neurotransmission
via the N-methyl-D-aspartate (NMDA) receptors contributes to the pathophysiology of …
via the N-methyl-D-aspartate (NMDA) receptors contributes to the pathophysiology of …
Recent developments in glycine transporter-1 inhibitors
CL Cioffi, S Liu, MA Wolf - Annual reports in medicinal chemistry, 2010 - Elsevier
Publisher Summary This chapter discusses the recent developments made in glycine
transporter–1 inhibitor. The growing body of evidence implicating N-methyl-D-aspartate …
transporter–1 inhibitor. The growing body of evidence implicating N-methyl-D-aspartate …
Glutamate-based therapeutic approaches: inhibitors of glycine transport
SM Lechner - Current opinion in pharmacology, 2006 - Elsevier
A growing body of evidence suggests that activation of the glutamatergic system, particularly
N-methyl-d-aspartate (NMDA) receptor function, may be a viable approach to the treatment …
N-methyl-d-aspartate (NMDA) receptor function, may be a viable approach to the treatment …
Glycine transporter type-1 and its inhibitors
LG Harsing Jr, Z Juranyi, I Gacsalyi… - Current medicinal …, 2006 - ingentaconnect.com
The ionotropic glutamate receptor NMDA is allosterically modulated by glycine, a coagonist,
its presence is an absolute requirement for receptor activation. The transport of glycine in …
its presence is an absolute requirement for receptor activation. The transport of glycine in …
Inhibitors of glycine transporter-1: potential therapeutics for the treatment of CNS disorders
CL Cioffi, PR Guzzo - Current Topics in Medicinal Chemistry, 2016 - ingentaconnect.com
Glycine acts as an inhibitory neurotransmitter at glycine receptor (GlyR)-enriched synapses
and as an obligatory co-agonist at the N-methyl-D-aspartate (NMDA) receptor, where it …
and as an obligatory co-agonist at the N-methyl-D-aspartate (NMDA) receptor, where it …
Inhibition of glycine transporter 1: the yellow brick road to new schizophrenia therapy?
P Singer, S Dubroqua, BK Yee - Current pharmaceutical …, 2015 - ingentaconnect.com
While pharmacological blockade of dopamine D2 receptor can effectively suppress the
psychotic or positive symptoms of schizophrenia, there is no satisfactory medication for the …
psychotic or positive symptoms of schizophrenia, there is no satisfactory medication for the …
Glycine transporters and their inhibitors
R Gilfillan, J Kerr, G Walker, G Wishart - Transporters as targets for drugs, 2009 - Springer
Glycine plays a ubiquitous role in many biological processes. In the central nervous systemit
serves as an important neurotransmitter acting as an agonist at strychnine-sensitive glycine …
serves as an important neurotransmitter acting as an agonist at strychnine-sensitive glycine …